An overview of the role of statins in reducing in-hospital deaths due to COVID-19, using findings from the American Heart Association’s COVID-19 Cardiovascular Disease Registry.
Compared with nonpharmacologic approaches, research consistently supports the benefits of medication for opioid use disorder, including fewer deaths, higher rates of sustained recovery, and greater cost-effectiveness.
A consensus statement from the Gout, Hyperuricemia and Crystal-Associated Disease Network (G-CAN) included key areas for research to address challenges in the management of gout in patients with chronic kidney disease.
In patients with RA, engaging in risk-stratification practices can mitigate the potential for fatalities of reactivated HBV, with pretherapy screening the most effective tool currently available.
GAPNA discusses how advanced practice practitioners are well-positioned to encourage healthy lifestyles among older adults, to include activities that help attain/maintain lean muscle mass, regardless of BMI, to reduce chronic pain and frailty.
Using Critical Race Theory, lead study author Rodlescia S. Sneed, PhD, MPH, and team assess the impact of racism on the representation of Black women with systemic lupus erythematosus in clinical trials, and highlight the need for interventions in this area.
In an interview, Brian LaMoreaux, MD, MS, discusses the need for evidence-based strategies to improve outcomes for patients hospitalized with gout.
Zachary S. Wallace, MD, discusses with us the effect of the COVID-19 pandemic on patients with rheumatoid arthritis (RA) and disease management during this period.
The pandemic has accelerated the number of clinicians retiring from practice.
Katy Leung, MD, provides insight into the existing sex and gender differences between men and women with axial spondyloarthritis.